Microvast (NASDAQ: MVST) grows 2025 revenue 12.6% and turns adjusted EBITDA positive

Rhea-AI Filing Summary

Microvast Holdings reported full-year 2025 revenue of $427.5 million, up 12.6% from 2024, with gross margin of 28.6% after a $32.5 million energy storage inventory impairment. The GAAP net loss narrowed sharply to $29.2 million from $195.5 million, while non-GAAP adjusted net profit reached $13.0 million and non-GAAP adjusted EBITDA improved to $44.7 million from a $44.8 million loss in 2024.

In Q4 2025, revenue was $96.4 million, down 15.0% year over year, and gross margin fell to 1.0% due to $29.0 million of impairment charges. Q4 GAAP net profit was $16.5 million, but non-GAAP adjusted net loss was $34.5 million. Cash, cash equivalents and restricted cash rose to $169.2 million as of December 31, 2025, from $109.6 million a year earlier.

Management expects continued revenue growth in 2026, targets maintaining a strong gross margin position, and is focused on achieving serial production at the Huzhou Phase 3.2 expansion and starting pack line operations in Clarksville, Tennessee by year-end, while pursuing high-barrier segments across EMEA, North America and APAC.

Positive

• Strong improvement in profitability metrics: 2025 GAAP net loss narrowed to $29.2 million from $195.5 million in 2024, while non-GAAP adjusted net profit reached $13.0 million and adjusted EBITDA swung from a $44.8 million loss to a $44.7 million profit.
• Healthy revenue growth and regional expansion: Full-year 2025 revenue grew 12.6% to $427.5 million, with U.S. revenue up 173% year over year to $39.3 million and EMEA revenue up 13% to $211.9 million.
• Stronger liquidity and operating cash flow: Cash, cash equivalents and restricted cash increased to $169.2 million at December 31, 2025, from $109.6 million a year earlier, supported by $75.9 million of net cash generated from operating activities.
• Clear 2026 operational roadmap: The company plans serial production at the Huzhou Phase 3.2 expansion and anticipates pack line operations in Clarksville, Tennessee by year end, aiming to support growth and high-barrier market segments.

Negative

• Q4 2025 revenue decline and margin compression: Fourth quarter 2025 revenue fell 15.0% year over year to $96.4 million, and gross margin dropped to 1.0% due to significant inventory impairment charges.
• Large impairment charges on energy storage components: A $32.5 million inventory impairment related to specialized energy storage system components reduced 2025 gross margin by 7.6 percentage points and contributed to volatility in quarterly results.
• Non-GAAP loss in Q4 despite GAAP profit: While Q4 2025 GAAP net profit was $16.5 million, non-GAAP adjusted net loss was $34.5 million, indicating underlying operating challenges once fair value changes and share-based compensation are excluded.
• Exposure to regulatory and market timing risks: Management cited regulatory shifts in South Korea and customer platform ramp-up delays in EMEA as drivers of revenue shortfalls versus guidance and Q4 revenue decline.

Insights

Equity analyst

Microvast shows a major profitability and cash flow improvement in 2025, but Q4 margins were hit by large impairments.

Microvast delivered $427.5 million of 2025 revenue, up 12.6%, and turned non-GAAP adjusted EBITDA from a $44.8 million loss in 2024 to a $44.7 million profit. GAAP net loss shrank to $29.2 million from $195.5 million, supported by lower operating expenses and subsidy income.

The year’s gross margin was 28.6%, down from 31.5%, mainly because of a $32.5 million energy storage system inventory impairment. Q4 2025 highlighted this pressure: revenue declined 15.0% to $96.4 million and gross margin fell to 1.0% after $29.0 million of impairment, leading to a Q4 non-GAAP adjusted net loss of $34.5 million.

On the balance sheet, cash, cash equivalents and restricted cash increased to $169.2 million at December 31, 2025, from $109.6 million a year earlier, helped by positive operating cash flow of $75.9 million. Management’s 2026 focus on Huzhou Phase 3.2 serial production, Clarksville pack localization, and high-margin segments suggests continued capacity expansion alongside an emphasis on maintaining its gross margin profile.

0001760689FALSE00017606892026-03-162026-03-160001760689us-gaap:CommonStockMember2026-03-162026-03-160001760689us-gaap:WarrantMember2026-03-162026-03-16

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 16, 2026

Microvast Holdings, Inc.

(Exact name of registrant as specified in its charter)

Delaware						001-38826			83-2530757
(State or other jurisdiction of incorporation)						(Commission File Number)			(IRS Employer Identification No.)
12603 Southwest Freeway, Suite 300
Stafford, Texas									77477
(Address of principal executive offices)									(Zip Code)

Registrant’s telephone number, including area code: (281) 491-9505

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common stock, par value $0.0001 per share

MVST

The NASDAQ Stock Market LLC

Redeemable warrants, exercisable for shares of common stock at an exercise price of $11.50 per share

MVSTW

The NASDAQ Stock Market LLC

Item 2.02 Results of Operations and Financial Condition.

On March 16, 2026, Microvast Holdings, Inc. issued a press release announcing its consolidated financial results for the fourth quarter and year ended December 31, 2025. A copy of the press release and the slideshow is furnished herewith as Exhibit 99.1 and 99.2, respectively to this Current Report on Form 8-K and each is incorporated herein by reference.

The information furnished in this Current Report on Form 8-K and the accompanying Exhibit 99.1 and 99.2 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing, unless expressly incorporated by reference in such a filing.

Item 9.01 Financial Statements and Exhibits

(d)Exhibits

Exhibit No.						Description
99.1						Press Release dated March 16, 2026
99.2						Presentation dated March 16, 2026
104						Cover Page Interactive Data File (embedded within the Inline XBRL document)

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: March 16, 2026			MICROVAST HOLDINGS, INC.
			By:			/s/ Rodney Worthen
			Name:			Rodney Worthen
			Title:			Chief Financial Officer

2

Exhibit 99.1

Microvast Reports 2025 Financial Results

•Full Year revenue increased 12.6% year over year to a record $427.5 million

•Full Year net loss of $29.2 million, compared to net loss of $195.5 million in 2024; Non-GAAP adjusted net profit of $13.0 million, compared to non-GAAP adjusted net loss of $84.6 million in 2024

STAFFORD, Texas, USA – Microvast Holdings, Inc. (NASDAQ: MVST) (“Microvast” or the “Company”), a global leader in advanced battery technologies, announced today its consolidated financial results for the fourth quarter and full fiscal year ended December 31, 2025 (“Q4 2025” and “FY 2025,” respectively).

“We achieved record revenue in 2025, capping off a year of significant progress. While our full-year revenue of $427.5 million landed below our guidance due to both evolving regulatory shifts in the Korean market and customer platform ramp up delays, our underlying fundamentals remain strong. We delivered 2025 revenue growth of 12.6%, demonstrating the high value our customers place on Microvast’s technology,” said Yang Wu, Microvast’s Founder, Chairman, and Chief Executive Officer. “The momentum in EMEA is encouraging as we continue into 2026, particularly as previous vehicle platform delays in the region begin to resolve. In APAC, we are focused on the long-term via our Huzhou Phase 3.2 expansion, which is expected to bring additional capacity online and we anticipate achieving serial production in 2026 after the ramp up period. Our core focus remains unchanged, scaling our global footprint and achieving profitability.”

Full Year 2025 Highlights

•Record yearly revenue of $427.5 million, an increase of 12.6% compared to $379.8 million in 2024

•Gross margin decreased to 28.6%, compared to 31.5% in 2024, this change was primarily attributable to a $32.5 million inventory impairment charge related to specialized ESS components, which negatively impacted our gross margin by 7.6 percentage points; Non-GAAP adjusted gross margin decreased to 28.6%, compared to 32.4% in 2024

•Operating expenses of $118.3 million, a decrease of 50.4% compared to $238.3 million in 2024; Non-GAAP adjusted operating expenses of $115.4 million, compared to $210.9 million in 2024

•Net loss of $29.2 million, compared to net loss of $195.5 million in 2024; Non-GAAP adjusted net profit of $13.0 million, compared to non-GAAP adjusted net loss of $84.6 million in 2024

•Net loss per share of $0.09 compared to net loss per share of $0.61 in 2024; Non-GAAP adjusted net profit per share of $0.04, compared to non-GAAP adjusted net loss per share of $0.27 in 2024

•Non-GAAP adjusted EBITDA of positive $44.7 million, compared to Non-GAAP adjusted EBITDA of negative $44.8 million in 2024

•Capital expenditures of $38.7 million, compared to $49.9 million in 2024, driven primarily by investments in manufacturing capacity expansion for our Huzhou Phase 3.2 line

•Cash, cash equivalents, restricted cash of $169.2 million as of December 31, 2025, compared to $109.6 million as of December 31, 2024

Fourth Quarter 2025 Highlights

•Revenue of $96.4 million, compared to $113.4 million in Q4 2024, a decrease of 15.0% as a result of regulatory shifts in South Korea and delays in customer platform ramp up in EMEA

•Gross margin decreased to 1.0%, compared to 36.6% in Q4 2024, this change was primarily attributable to inventory impairment charges, which negatively impacted our gross margin by 30.1 percentage points; Non-GAAP adjusted gross margin decreased to 1.0%, compared to 36.7% in Q4 2024

•Operating expenses of $42.8 million, compared to $43.2 million in Q4 2024; Non-GAAP adjusted operating expenses of $42.0 million, compared to $42.8 million in Q4 2024

•Net profit of $16.5 million, compared to net loss of $82.3 million in Q4 2024; Non-GAAP adjusted net loss of $34.5 million, compared to non-GAAP adjusted net loss of $0.6 million in Q4 2024

•Net profit per share of $0.05, compared to net loss per share of $0.26 in Q4 2024; Non-GAAP adjusted net loss per share of $0.11, compared to non-GAAP adjusted net loss per share of $0.01 in Q4 2024

•Non-GAAP adjusted EBITDA of negative $31.6 million, compared to Non-GAAP adjusted EBITDA of positive $8.6 million in Q4 2024

•Capital expenditures of $7.3 million, compared to $6.1 million in Q4 2024

Please refer to the tables at the end of this press release for reconciliations of gross profit to non-GAAP adjusted gross profit, operating expenses to non-GAAP adjusted operating expenses, net profit/(loss) to non-GAAP adjusted net profit/(loss), net profit/(loss) per share to non-GAAP adjusted net profit/(loss) per share, net profit/(loss) to non-GAAP adjusted EBITDA and gross margin to non-GAAP adjusted gross margin.

2026 Outlook & Forward-Looking Information

•While we are navigating evolving tariff structures and shifting regulatory and geopolitical events, we expect continued revenue growth in 2026

•We are targeting maintaining a strong gross margin position, striking a balance between maintained operational efficiencies, planned absorption of costs associated with the Huzhou Phase 3.2 ramp-up period, and commodity price fluctuation

•Our primary operational focus remains the achievement of serial production at our Huzhou Phase 3.2 expansion in 2026, which is expected to bring online additional capacity to meet customer demand of current and upcoming cell technologies

•Anticipate pack line operations in Clarksville by year end for U.S. commercial vehicle customers as we assess domestic opportunities and operations

2

•Continue to seek new customer pipelines that span across EMEA, North America, and APAC, with a focus on high-barrier-to-entry segments, such as heavy industrials and transit, in which we believe we have a competitive advantage

Webcast Information

Company management will host a conference call and webcast on March 16, 2026, at 4:00 p.m. Central Time, to discuss the Company's financial results. The live webcast and accompanying slide presentation will be accessible from the Events & Presentations section of Microvast’s investor relations website (https://ir.microvast.com/events-presentations/events). A replay will be available following the conclusion of the event.

About Microvast

Microvast is a global leader in providing battery technologies for electric vehicles and energy storage solutions. With a legacy of over 19 years, Microvast has consistently delivered cutting-edge battery systems that empower a cleaner and more sustainable future. The Company's innovative approach and dedication to excellence have positioned it as a trusted partner for customers around the world. Founded in 2006 in Stafford, Texas, Microvast holds more than 890 patents that enable solutions for today’s electrification needs.

For more information, please visit www.microvast.com or follow us on LinkedIn (@microvast).

Contact:

Investor Relations

ir@microvast.com

Cautionary Statement Regarding Forward-Looking Statements

This communication contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on assumptions with respect to the future and management's current expectations, involve certain risks and uncertainties and are not guarantees. These forward-looking statements include, but are not limited to, statements about our future results of operations and financial position, our operational performance, our anticipated growth and business strategy, our future capital expenditures and debt service obligations, the projected costs, prospects and plans and objectives of management for future operations, including regarding expected growth and demand for our batteries and energy storage solutions and introduction of new batteries and energy storage solutions, the adoption of such offerings by customers, our expectations relating to backlog, pipeline and contracted backlog, current expectations relating to legal proceedings and anticipated impacts and benefits from the Inflation Reduction Act of 2022 as well as any other proposed or recently enacted legislation. In some cases, you may also identify forward-looking statements by words such as “anticipate,” “believe,” “can,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “objective,” “plan,” “project,” “predict,” “outlook” “should,” “will,” “would,” or the negative of these terms, or other comparable terminology intended to identify statements about the future. Such forward-looking statements are based upon the current beliefs and expectations of management and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are difficult to predict and generally beyond our control. Actual results and the timing of events may differ materially from the results anticipated in these forward-looking statements. We do not assume any obligation to update any forward-looking statements.

3

Many factors could cause actual results and the timing of events to differ materially from the anticipated results or other expectations expressed in the forward-looking statements, including, among others: (1) our ability to remain a going concern; (2) risk that we may not be able to accurately project and manage our growth and effectively execute our growth strategies or achieve profitability; (3) risk that we may be unable to meet our future capital requirements and we may require additional capital to support our business growth, and this capital might not be available on acceptable terms, or at all; (4) potential difficulties in maintaining manufacturing capacity and establishing expected mass manufacturing capacity in the future; (5) risks relating to issues or delays, disruptions and quality control problems in our manufacturing operations; (6) risks relating to being unable to control our manufacturing costs; (7) risks that we may be unable to meet our projected construction timelines, costs and production ramps, or we may experience difficulties in generating and maintaining demand for products manufactured there and related services; (8) restrictions in our existing and any future credit facilities; (9) risks of operations in China; (10) the effects of mechanics liens filed by contractors that we do not have sufficient funds to pay; (11) the effects of existing and future litigation; (12) changes in general economic conditions, including increases in interest rates and associated Federal Reserve policies, a potential economic recession, and the impact of inflation on our business; (13) changes in the highly competitive market in which we compete, including with respect to our competitive landscape, technology evolution or regulatory changes; (14) changes in availability and price of raw materials; (15) risks that our suppliers may fail to deliver components according to schedules, prices, quality and volumes that are acceptable to us, or we may be unable to manage these components effectively; (16) labor relations, including the ability to attract, hire and retain key employees and contract personnel; (17) heightened awareness of environmental issues and concern about global warming and climate change; (18) risk that we are unable to secure or protect our intellectual property; (19) risk that our customers or third-party suppliers are unable to meet their obligations fully or in a timely manner; (20) risks related to possible future reductions in pricing or order volume or loss of one or more of our significant customers; (21) risks relating to our status as a relatively low-volume purchaser as well as from supplier concentration and limited supplier capacity; (22) risk that our customers will adjust, cancel or suspend their orders for our products; (23) risks relating to our ability to attract new customers and retain existing customers; (24) risks related to our lengthy sales cycle for our products; (25) risk of product liability or regulatory lawsuits or proceedings relating to our products or services; (26) our ability to maintain and enhance our reputation and brand recognition; (27) risks relating to facing strong competition for our products and services from a growing list of established and new competitors; (28) the effectiveness of our information technology and operational technology systems and practices to detect and defend against evolving cyberattacks; (29) changing laws regarding cybersecurity and data privacy, and any cybersecurity threat or event; (30) the effects and associated cost of compliance with existing and future laws and governmental regulations, such as the Inflation Reduction Act; (31) risks relating to whether renewable energy technologies are suitable for widespread adoption or if sufficient demand for our offerings does not develop or takes longer to develop than we anticipate; (32) economic, financial and other impacts such as a pandemic, including global supply chain disruptions; (33) the impacts of geopolitical events, such as the ongoing conflicts in the Middle East, including hostilities with Iran, the war between Russia and Ukraine, and other current or future conflicts; (34) risks associated with maintaining and expanding our international operations, including unfavorable and uncertain regulatory, political, economic, tax, and labor conditions; and (35) risk that tariffs imposed on products of the PRC into the United States may lead to increased costs and impact our business. Microvast’s annual, quarterly and other filings with the U.S. Securities and Exchange Commission identify, address and discuss these and other factors in the sections entitled “Risk Factors.”

Actual results, performance or achievements may differ materially, and potentially adversely, from any forward-looking statements and the assumptions on which those forward-looking statements are based. There can be no assurance that the data contained herein is reflective of future performance to any degree. You are cautioned not to place undue reliance on forward-looking statements as a predictor of future performance as forward-looking statements are based on estimates and

4

assumptions that are inherently subject to various significant risks, uncertainties and other factors, many of which are beyond our control.

All information set forth herein speaks only as of the date hereof, and we disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date hereof except as may be required under applicable securities laws. Forecasts and estimates regarding our industry and end markets are based on sources we believe to be reliable, however, there can be no assurance these forecasts and estimates will prove accurate in whole or in part.

All references to the “Company,” “we,” “us” or “our” refer to Microvast Holdings, Inc. and its consolidated subsidiaries other than certain historical information which refers to the business of Microvast prior to the consummation of the Business Combination.

Non-GAAP Financial Measures

To provide investors with additional information regarding our financial results, Microvast has disclosed in this earnings release non-GAAP financial measures, including non-GAAP adjusted gross profit, non-GAAP EBITDA, non-GAAP adjusted EBITDA, non-GAAP adjusted operating expenses, non-GAAP adjusted net profit/(loss), net profit/(loss) per share to non-GAAP adjusted net profit/(loss) per share, and non-GAAP adjusted gross margin which are non-GAAP financial measures as defined under the rules of the SEC. These are intended as supplemental measures of our financial performance that are not required by, or presented in accordance with U.S. generally accepted accounting principles (“GAAP”).

Reconciliations to the most comparable GAAP measures, gross profit, gross margin, operating expenses, net profit/(loss), and net profit/(loss) per share, are contained in tabular form in the unaudited financial statements below. Non-GAAP adjusted gross profit is GAAP gross profit as adjusted for non-cash share-based compensation expense included in cost of revenues. Non-GAAP adjusted net profit/(loss) is GAAP net profit/(loss) as adjusted for non-cash share-based compensation expense and change in valuation of warrant liability and convertible loan. Non-GAAP adjusted net profit/(loss) per common share is GAAP net profit/(loss) per common share as adjusted for non-cash share-based compensation expense and change in valuation of warrant liability and convertible loan per common share. Non-GAAP EBITDA is defined as net profit/(loss) excluding depreciation and amortization, interest expense, interest income, and income tax expense or benefit. Non-GAAP adjusted EBITDA is defined as net profit/(loss) excluding depreciation and amortization, non-cash settled share-based compensation expense, interest expense, interest income, changes in fair value of our warrant liability and convertible loan and income tax expense or benefit. Non-GAAP adjusted operating expenses is defined as operating expenses excluding non-cash share-based compensation expense. Non-GAAP adjusted gross margin is defined as GAAP gross margin as adjusted for non-cash share-based compensation expense included in cost of revenues.

We use non-GAAP adjusted gross profit, non-GAAP EBITDA, non-GAAP adjusted EBITDA, non-GAAP adjusted operating expenses, non-GAAP adjusted net profit/(loss), non-GAAP net profit/(loss) per share and non-GAAP adjusted gross margin for financial and operational decision-making and as a means to evaluate period-to-period comparisons. We consider them to be important measures because they help illustrate underlying trends in our business and our historical operating performance on a more consistent basis. We believe that these non-GAAP financial measures, when taken together with their most directly comparable GAAP measures, provide meaningful supplemental information regarding our performance by excluding certain items that may not be indicative of our recurring core business operating results.

We believe that both management and investors benefit from referring to these non-GAAP financial measures in assessing our performance and when planning, forecasting, and analyzing future

5

periods. These non-GAAP financial measures also facilitate management’s internal comparisons to our historical performance. We believe these non-GAAP financial measures are useful to investors both because (1) they allow for greater transparency with respect to key metrics used by management in its financial and operational decision-making and (2) they are used by our institutional investors and the analyst community to help them analyze the health of our business. Accordingly, we believe that these non-GAAP financial measures provide useful information to investors and others in understanding and evaluating our operating results in the same manner as our management team and board of directors.

Non-GAAP financial measures have limitations as an analytical tool, and you should not consider them in isolation, or as a substitute for, financial information prepared in accordance with GAAP. For example, our calculation of non-GAAP adjusted EBITDA may differ from similarly titled non-GAAP measures, if any, reported by our peer companies, or our peer companies may use other measures to calculate their financial performance, and therefore our use of non-GAAP adjusted EBITDA may not be directly comparable to similarly titled measures of other companies. The principal limitation of non-GAAP adjusted EBITDA is that it excludes significant expenses and income that are required by GAAP to be recorded in our financial statements. In addition, it is subject to inherent limitations as it reflects the exercise of judgments by management about which expense and income are excluded or included in determining this non-GAAP financial measure. In order to compensate for these limitations, management presents non-GAAP financial measures in connection with GAAP results. In addition, such financial information is unaudited and does not conform to SEC Regulation S-X and as a result, such information may be presented differently in our future filings with the SEC. For example, with respect to the warrant liability resulting from the July 23, 2021 business combination with Tuscan Holdings Corp., we now exclude changes in fair value from net profit/(loss) in our non-GAAP adjusted EBITDA and non-GAAP adjusted net profit/(loss) calculation, which had not been done in prior periods.

6

MICROVAST HOLDINGS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands of U.S. dollars, except share and per share data, or as otherwise noted)

			December 31
			2025						2024
Assets
Current assets:
Cash and cash equivalents			$	104,963					$	73,007
Restricted cash			64,275						36,572
Short-term investments			—						—
Accounts receivable (net of allowance for credit losses of $4,693 and $5,090 as of December 31, 2025 and 2024, respectively)			155,763						120,626
Notes receivable			5,590						7,579
Inventories, net			89,411						143,327
Prepaid expenses and other current assets			17,221						27,019
Assets held for sale			11,500						19,896
Total Current Assets			448,723						428,026
Restricted cash			—						22
Property, plant and equipment, net			508,057						478,189
Land use rights, net			11,570						11,371
Acquired intangible assets, net			2,183						2,607
Operating lease right-of-use assets			17,336						17,628
Deferred tax assets			5,429						—
Other non-current assets			12,150						14,024
Total Assets			$	1,005,448					$	951,867
Liabilities
Current liabilities:
Accounts payable			$	47,003					$	64,940
Advance from customers			5,605						43,678
Accrued expenses and other current liabilities			123,315						98,456
Amounts due to related parties			2						5
Income tax payables			99						652
Convertible loan measured at fair value			140,929						—
Short-term bank borrowings			93,052						70,666
Notes payable			78,321						51,756
Warrant liability			15						—
Total Current Liabilities			488,341						330,153
Long-term bank borrowings			13,227						41,062
Long-term bonds payable			41,693						43,157
Warrant liability			—						290
Share-based compensation liability			98						98
Operating lease liabilities			14,476						14,596
Convertible loan measured at fair value			—						104,613
Other non-current liabilities			37,100						30,003
Total Liabilities			$	594,935					$	563,972
Total Equity			$	410,513					$	387,895
Total Liabilities and Equity			$	1,005,448					$	951,867

7

MICROVAST HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands of U.S. dollars, except share and per share data, or as otherwise noted)

			Year Ended December 31,
			2025						2024
Revenues			$	427,516					$	379,801
Cost of revenues			(272,899)						(260,249)
Energy storage system impairment			(32,507)						—
Gross profit			122,110						119,552
Operating expenses:
General and administrative expenses			(57,821)						(81,486)
Research and development expenses			(34,109)						(41,065)
Selling and marketing expenses			(22,197)						(22,576)
Impairment loss of long-lived assets			(4,142)						(93,173)
Total operating expenses			(118,269)						(238,300)
Subsidy income			3,142						2,658
Income/(loss) from operations			6,983						(116,090)
Other income and expenses:
Interest income			957						742
Interest expense			(4,903)						(9,711)
Changes in fair value of warrant liability and convertible loan			(39,121)						(79,960)
Gain on debt restructuring			1,297						9,406
Other income net			244						156
Loss before provision for income tax			(34,543)						(195,457)
Benefit from income taxes			5,325						—
Net loss			$	(29,218)					$	(195,457)
Less: net loss attributable to noncontrolling interests			—						—
Net loss attributable to common stockholders			(29,218)						(195,457)
Net loss per common share - basic and diluted			$	(0.09)					$	(0.61)
Weighted average shares outstanding - basic and diluted			324,689,242						318,462,843

8

MICROVAST HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited, in thousands of U.S. dollars, except share and per share data, or as otherwise noted)

			Three Months Ended December 31,
			2025						2024
Revenues			$	96,399					$	113,387
Cost of revenues			(66,442)						(71,867)
Energy storage system impairment			(28,998)						—
Gross profit			959						41,520
Operating expenses:
General and administrative expenses			(23,708)						(22,340)
Research and development expenses			(10,385)						(8,774)
Selling and marketing expenses			(5,968)						(6,996)
Impairment loss of long-lived assets			(2,742)						(5,134)
Total operating expenses			(42,803)						(43,244)
Subsidy income			687						307
Loss from operations			(41,157)						(1,417)
Other income and expenses:
Interest income			346						191
Interest expense			(1,208)						(1,595)
Changes in fair value of warrant liability and convertible loan			51,881						(81,200)
Gain on debt restructuring			505						1,249
Other (expense)/ income, net			(112)						449
Loss before provision for income tax			10,255						(82,323)
Benefit from income taxes			6,284						—
Net income/(loss)			$	16,539					$	(82,323)
Less: Net loss attributable to noncontrolling interest			—						—
Net income/(loss) attributable to common shareholders			$	16,539					$	(82,323)
Net income/(loss) per common share
Basic			$	0.05					$	(0.26)
Diluted			0.05						(0.26)
Weighted average shares outstanding:
Basic			327,929,738						322,327,294
Diluted			337,428,861						322,327,294

9

MICROVAST HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands of U.S. dollars, except share and per share data, or as otherwise noted)

			Year Ended December 31,
			2025						2024
Cash flows from operating activities
Net loss			$	(29,218)					$	(195,457)
Adjustments to reconcile net loss to net cash used in operating activities:
Loss on disposal of property, plant and equipment			414						844
Gain on debt restructuring			(1,297)						(9,406)
Interest expense			—						2,248
Depreciation of property, plant and equipment			32,358						30,057
Amortization of land use rights and intangible assets			773						775
Noncash lease expenses			2,617						2,686
Share-based compensation			3,072						30,840
Changes in fair value of warrant liability and convertible loan			39,121						79,960
Allowance of credit losses			7,991						3,743
Write-down for obsolete inventories			33,722						3,286
Impairment loss of long-lived assets			4,142						93,173
Product warranty			17,173						12,826
Deferred income taxes			(5,429)						—
Changes in operating assets and liabilities:
Notes receivable			(27,343)						6,488
Accounts receivable			(27,259)						8,791
Inventories			27,089						(546)
Prepaid expenses and other current assets			8,900						3,289
Amounts due from/to related parties			(3)						5
Operating lease right-of-use assets			(475)						(1,780)
Other non-current assets			629						(973)
Notes payable			24,048						(9,911)
Accounts payable			(20,193)						(44,523)
Advance from customers			(38,347)						836
Accrued expenses and other liabilities			20,587						(16,486)
Operating lease liabilities			(1,786)						(1,607)
Other non-current liabilities			4,622						3,656
Net cash generated from operating activities			75,908						2,814
Cash flows from investing activities
Purchases of property, plant and equipment			(19,834)						(27,721)
Proceeds on disposal of property, plant and equipment			3,789						10,005
Purchase of short-term investments			—						—
Proceeds from maturity of short-term investments			—						5,564
Net cash used in investing activities			(16,045)						(12,152)
Cash flows from financing activities
Proceeds from bank borrowings			85,708						101,517
Repayment of bonds payable			(1,375)						—
Repayment of bank borrowings			(96,070)						(66,248)
Convertible loan			—						25,000
Payment for debt issuance costs			—						(525)
Proceeds from sale of common stocks			28,750						—
Payment for equity issuance costs			(809)						—
Deferred payment related to purchases of property, plant and equipment			(18,887)						(22,155)
Net cash (used in)/generated from financing activities			(2,683)						37,589
Effect of exchange rate changes			2,457						(6,839)
Increase in cash, cash equivalents and restricted cash			59,637						21,412
Cash, cash equivalents and restricted cash at beginning of the year			109,601						88,189
Cash, cash equivalents and restricted cash at end of the year			$	169,238					$	109,601

10

MICROVAST HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands of U.S. dollars, except share and per share data, or as otherwise noted)

			Year Ended December 31,
			2025						2024
Reconciliation to amounts on consolidated balance sheets
Cash and cash equivalents			$	104,963					$	73,007
Restricted cash			64,275						36,594
Total cash, cash equivalents and restricted cash			$	169,238					$	109,601

11

MICROVAST HOLDINGS, INC.

RECONCILIATION OF GROSS PROFIT TO ADJUSTED GROSS PROFIT

(In thousands of U.S. dollars, except share and per share data, or as otherwise noted)

			Three Months Ended December 31,												Twelve Months Ended December 31,
			2025						2024						2025						2024
Revenues			$	96,399					$	113,387					$	427,516					$	379,801
Cost of revenues			(66,442)						(71,867)						(272,899)						(260,249)
Energy storage system impairment			(28,998)						—						(32,507)						—
Gross profit (GAAP)			$	959					$	41,520					$	122,110					$	119,552
Gross margin			1.0		%				36.6		%				28.6		%				31.5		%
Non-cash settled share-based compensation (included in cost of revenues)			32						89						216						3,479
Adjusted gross profit (non-GAAP)			$	991					$	41,609					$	122,326					$	123,031
Adjusted gross margin (non-GAAP)			1.0		%				36.7		%				28.6		%				32.4		%

12

MICROVAST HOLDINGS, INC.

RECONCILIATION OF OPERATING EXPENSES TO ADJUSTED OPERATING EXPENSES

(In thousands of U.S. dollars, except share and per share data, or as otherwise noted)

			Three Months Ended December 31,												Twelve Months Ended December 31,
			2025						2024						2025						2024
General and administrative expenses			(23,708)						(22,340)						(57,821)						(81,486)
Research and development expenses			(10,385)						(8,774)						(34,109)						(41,065)
Selling and marketing expenses			(5,968)						(6,996)						(22,197)						(22,576)
Impairment loss of long-lived assets			(2,742)						(5,134)						(4,142)						(93,173)
Operating expenses (GAAP)			$	(42,803)					$	(43,244)					$	(118,269)					$	(238,300)
Non-cash settled share-based compensation (included in operating expenses)			763						462						2,856						27,370
Adjusted operating expenses (non-GAAP)			$	(42,040)					$	(42,782)					$	(115,413)					$	(210,930)

13

MICROVAST HOLDINGS, INC.

RECONCILIATION OF NET PROFIT/(LOSS) TO ADJUSTED NET PROFIT/(LOSS)

(In thousands of U.S. dollars, except share and per share data, or as otherwise noted)

			Three Months Ended December 31,												Twelve Months Ended December 31,
			2025						2024						2025						2024
Net profit/(loss) (GAAP)			$	16,539					$	(82,323)					$	(29,218)					$	(195,457)
Changes in fair value of warrant liability and convertible loan*			(51,881)						81,200						39,121						79,960
Non-cash settled share-based compensation*			795						551						3,072						30,849
Adjusted net (loss)/profit (non-GAAP)			$	(34,547)					$	(572)					$	12,975					$	(84,648)

*The tax effect of the adjustments was nil.

			Three Months Ended December 31,												Twelve Months Ended December 31,
			2025						2024						2025						2024
Net profit/(loss) per common share-Basic (GAAP)			$	0.05					$	(0.26)					$	(0.09)					$	(0.61)
Changes in fair value of warrant liability and convertible loan per common share			(0.16)						0.25						0.12						0.25
Non-cash settled share-based compensation per common share			—						—						0.01						0.09
Adjusted net (loss)/profit per common share-Basic (non-GAAP)			$	(0.11)					$	(0.01)					$	0.04					$	(0.27)

14

MICROVAST HOLDINGS, INC.

RECONCILIATION OF NET PROFIT/(LOSS) TO EBITDA AND ADJUSTED EBITDA

(In thousands of U.S. dollars, except share and per share data, or as otherwise noted)

			Three Months Ended December 31,												Twelve Months Ended December 31,
			2025						2024						2025						2024
Net profit/(loss) (GAAP)			$	16,539					$	(82,323)					$	(29,218)					$	(195,457)
Interest expense, net			862						1,404						3,946						8,969
Benefit from income taxes			(6,284)						—						(5,325)						—
Depreciation and amortization			8,384						7,809						33,131						30,832
EBITDA (non-GAAP)			$	19,501					$	(73,110)					$	2,534					$	(155,656)
Changes in fair value of warrant liability and convertible loan			(51,881)						81,200						39,121						79,960
Non-cash settled share-based compensation			795						551						3,072						30,849
Adjusted EBITDA (non-GAAP)			$	(31,585)					$	8,641					$	44,727					$	(44,847)

15

2 0 2 5

2 Disclaimer Forward-Looking Statements This communication contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about our future results of operations and financial position, our operational performance, our anticipated growth and business strategy, our future capital expenditures and debt service obligations, the projected costs, prospects and plans and objectives of management for future operations, including regarding expected growth and demand for our batteries and energy storage solutions and introduction of new batteries and energy storage solutions, the adoption of such offerings by customers, our expectations relating to backlog, pipeline and contracted backlog, current expectations relating to legal proceedings and anticipated impacts and benefits from the Inflation Reduction Act of 2022 as well as any other proposed or recently enacted legislation. In some cases, you may also identify forward-looking statements by words such as “anticipate,” “believe,” “can,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “objective,” “plan,” “project,” “predict,” “outlook” “should,” “will,” “would,” or the negative of these terms, or other comparable terminology intended to identify statements about the future. Such forward-looking statements are based upon the current beliefs and expectations of management and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are difficult to predict and generally beyond our control. Actual results and the timing of events may differ materially from the results anticipated in these forward-looking statements. Actual results, performance or achievements may differ materially, and potentially adversely, from any forward-looking statements and the assumptions on which those forward-looking statements are based. There can be no assurance that the data contained herein is reflective of future performance to any degree. You are cautioned not to place undue reliance on forward-looking statements as a predictor of future performance as forward-looking statements are based on estimates and assumptions that are inherently subject to various significant risks, uncertainties and other factors, many of which are beyond our control. All information set forth herein speaks only as of the date hereof, and we disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date hereof except as may be required under applicable securities laws. Forecasts and estimates regarding our industry and end markets are based on sources we believe to be reliable, however, there can be no assurance these forecasts and estimates will prove accurate in whole or in part. Microvast’s annual, quarterly and other filings with the U.S. Securities and Exchange Commission identify, address and discuss these and other factors in the section entitled “Risk Factors.” Non-GAAP Financial Measures This presentation contains EBITDA, adjusted EBITDA, and adjusted net profit/loss, which are non-GAAP financial measures. EBITDA is defined as net profit/(loss) excluding depreciation and amortization, interest expense, interest income, and income tax expense or benefit. Non-GAAP adjusted EBITDA is defined as net profit/loss excluding depreciation and amortization, non-cash settled share-based compensation (“SBC”) expense, interest expense, interest income, changes in fair value of our warrant and convertible loan and income tax expense or benefit. Adjusted net profit/loss is GAAP net profit/loss as adjusted for non-cash stock-based compensation expense and changes to the valuation of warrant liabilities and convertible loan. In addition to Microvast's results determined in accordance with GAAP, Microvast's management uses these non-GAAP financial metrics to evaluate the company’s ongoing operations and for internal planning and forecasting purposes. We believe that this non-GAAP financial information, when taken collectively, may be helpful to investors in assessing Microvast's operating performance. We believe that the use of these non-GAAP metrics provides an additional tool for investors to use in evaluating ongoing operating results and trends because it eliminates the effect of financing, non-recurring items, capital expenditures, and non-cash expenses. In addition, our presentation of EBITDA, adjusted EBITDA, and adjusted net profit/loss should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items. Our computation of non-GAAP financial metrics may not be comparable to other similarly titled measures computed by other companies because not all companies calculate these measures in the same fashion. Because of these limitations, these non-GAAP financial metrics should not be considered in isolation or as a substitute for performance measures calculated in accordance with GAAP. We compensate for these limitations by relying primarily on our GAAP results and using non-GAAP financial metrics on a supplemental basis. Investors should review the reconciliations in this presentation and not rely on any single financial measure to evaluate our business.

3 Click to edit text Microvast Snapshot 19 Years of Innovation in Electrification We strive to be a trusted global leader in sustainable energy technologies and solutions. We aspire to be the company with continued groundbreaking battery innovation across the technology stack. We aim to become a steward of electric mobility and the shift towards a cleaner, greener, and more resilient planet. § 890+ Global Patents* Covering Our Technology § NASDAQ: MVST (Founded in 2006 in TX) § Electrifying Products Worldwide Upcoming Launches of New Products 37Ah – Fast Charging, High Power § Ultra-fast charging and high-power performance combined with a long cycle life for rail and tram systems, AGVs, and high-torque robotics in environments where power must be delivered & recharged rapidly for 24/7 operations. 55Ah – Where Power & Energy Converge § Purpose-built for segments where range and longevity are paramount, from city buses to heavy-duty trucks. § Delivering both the power and the energy density required to keep these fleets running longer. *Patents granted or pending; held by Company and our subsidiaries as of 3/16/2025.

4 Microvast FY2025 Overview Realizing Results FY Revenue FY Gross Profit & Gross Margin § Revenue Growth – more than doubled since 2022, showing rising market demand for our innovative technologies. § Gross Profit Trend – gross profit improvement of ~13x since 2022, showing maturity within our industry. § Adjusted EBITDA – improving operational profitability while growing business and manufacturing capacity. Revenue $427.5M +12.6% Y/Y Gross Margin 28.6% Sustainable Performance Adj. EBITDA $44.7M Operational Execution FY Adjusted EBITDA GAAP Net Loss $29.2M +$166M Y/Y $204.5 $306.6 $379.8 $427.5 2 0 2 2 2 0 2 3 2 0 2 4 2 0 2 5 M IL LI O N S U SD $(56.7) $(19.6) $(44.8) $44.7 2 0 2 2 2 0 2 3 2 0 2 4 2 0 2 5 M IL LI O N S U SD $9.1 $57.2 $119.6 $122.1 $154.6 4. 4% 18 .7 % 31 .5 % 28 .6 % 36 .2 % 0% 20% 40% 60% 80% 100% $0 $50 $100 $150 $200 2 0 2 2 2 0 2 3 2 0 2 4 2 0 2 5 G RO SS M A RG IN % M IL LI O N S U SD

5 Phase 3.2 Update Capacity Expansion Expanding our Huzhou facility with Phase 3.2 will allow us to deliver more products to more customers: ü Clean rooms are completed and in use. ü Utility equipment installation completed and in operation. ü HpCO-55Ah trial production has begun on electrode section, assembly, and formation; no-load running tests have started. Ø Expected to provide up to an additional 2GWh of capacity annually. Ø Anticipated capability of producing both current and upcoming advanced cells such as HpCO-53.5Ah/HpCO-55Ah/HnCO-120Ah.

6 High Energy Applications: High-Power Applications: 2026 Upcoming Launches of New Products HpCO-55Ah: High Power, Meet High Energy HpTO-37Ah: High Power, Ultra Fast Charging Optimized for Low Total Cost of Ownership & Maximum Vehicle Uptime § Bus § Mining Truck § Maritime § Taxi § PHEV § LCV § Heavy duty truck § Rail & Tram § AGVs / AMRs § Forklift § Mining Truck § High-torque Robotics § Heavy Duty Truck

7 All-Solid-State Battery: Scaling Milestones Pioneering High-Voltage Bipolar Integration 48-Volt Monolithic Stack (12-Layer Update, 200 cycles) § 99.97% Coulombic efficiency at 1C, indicating minimal energy loss and durability. § Successfully scaled architecture from 5 to 12 layers in a single, integrated stack. § The fully solid-state design eliminates liquid electrolytes, preventing degradation under high-voltage stress and improving safety. 72-Volt Monolithic Stack (New Voltage Milestone, 100 cycles) § Our highest voltage density to date, achieved through a proprietary, internally series-connected bipolar architecture. § SEM-EDS analysis confirms uniform layer construction, essential for long-term power stability. § Designed for direct integration into next-generation robotics and high-power systems, reducing weight and system complexity by eliminating external wiring. Figure 1: Voltage retention behavior of 48V monolithic solid- state stack over repeated cycling. Figure 2: Voltage–capacity profile of a 72V monolithic solid-state stack Figure 3: SEM-EDS cross-section confirming uniform layer construction.

2 0 2 5 F I N A N C I A L S

9 2025 P&L ($ in thousands) GAAP Income Statement Twelve-Months Ended Dec. 31 2025 2024 Revenue 427,516 379,801 Cost of revenues (272,899) (260,249) ESS impairment (32,507) - Gross Profit 122,110 119,552 Gross Margin 28.6% 31.5% General and administrative expenses (57,821) (81,486) Research and development expenses (34,109) (41,065) Selling and marketing expenses (22,197) (22,576) Impairment loss of long-lived assets (4,142) (93,173) Operating expense (118,269) (238,300) Subsidy Income 3,142 2,658 Profit/(loss) from operations 6,983 (116,090) Change in fair value of warrants and convertible loan (39,121) (79,960) Others (2,405) 593 Net profit/(loss) before income tax (34,543) (195,457) Benefit from income taxes 5,325 - Net profit/(loss) (29,218) (195,457) 2025 Revenue vs. 2024 § Revenue rose 12.6% year-over-year (“Y/Y”), driven by a ~266MWh increase in sales volume. § GAAP gross margin of 28.6% compared to 31.5% in 2024. This change was primarily attributable to a $32.5 million inventory impairment charge related to specialized ESS components, which negatively impacted our gross margin by 7.6 percentage points. 2025 Operating Expenses vs. 2024 § G&A: Decrease Y/Y primarily due to favorable FX and a reduction in non-cash settled share-based compensation (“SBC”). § R&D: Decrease primarily due to reduction in non-cash SBC and personnel costs Y/Y. § S&M: Remained relatively flat Y/Y. 2025 Performance § Adjusted net profit of $13.0M for the twelve-month period. § Adjusted EBITDA of $44.7M for the twelve-month period.

10 2025 Revenue by Region ($ in thousands) Revenue by region Twelve-Months Ended Dec. 31 2025 2024 Y/Y % APAC 176,267 177,696 -1% EMEA 211,944 187,718 13% USA 39,305 14,387 173% Total 427,516 379,801 13% Twelve-Months Ended Dec. 31 Revenue vs. Prior Year Period US Grew 173% year-over-year, from $14.4 million in 2024 to $39.3 million in 2025, contributing to 9% of our total revenue mix. This growth was primarily driven by customers bringing forward deliveries due to uncertainty on tariff outcomes. EMEA Our strongest market, with a 13% year-over-year revenue increase, growing to $211.9 million in 2025 compared to $187.7 million in 2024. APAC Revenue declined slightly from $177.7 million in 2024 to $176.3 million in 2025, a 1% year-over-year decrease, growth in deliveries was primarily offset by regulatory shifts in South Korea. APAC, 42% EMEA, 49% USA, 9% 2025 APAC, 46% EMEA, 50% USA, 4% 2024

11 Cash Flow Statement ($ in thousands) Operating Cash Flow § Net loss for the year was primarily offset by a $27.1M decrease in inventory, non-cash adjustments of $33.1M in D&A, $38.3M in impairment, disposal, and write downs, and $39.1M from changes in fair value of warrant liability and convertible loan. § Decreased by a $54.6M increase in net receivables and an $11.1M decrease in net liabilities and accrued expenses. Investing Activities § Net outflow of $16M, due to net PP&E primarily related to our Huzhou Phase 3.2 expansion. Financing Activities § $2.7M net outflow, including sales proceeds, re-financing, and repayments. Foreign Exchange Impact § $2.5M positive impact from exchange rate changes, reflecting global business and international exposure. Cash Position § Ended the period with $169.2M in cash (including restricted cash), a $59.6M increase, showing improved financial stability despite ongoing investments and growth. Condensed & Consolidated Cashflow Twelve-Months Ended Dec. 31 2025 GAAP net profit/(loss) (29,218) Operating activities: Impairment, disposal, write downs 38,278 Changes in fair value of warrant liability and convertible loan 39,121 Other operating activities 30,106 D&A 33,131 Non-cash settled share-based compensation 3,072 Net receivables (54,602) Inventory 27,089 Net liabilities & expenses (11,069) Net cash from operating activities 75,908 Investing activities: Net PP&E (16,045) Net cash from investing activities (16,045) Financing activities: Net proceeds 113,649 Net repayments (116,332) Net cash from financing activities (2,683) Exchange rate changes 2,457 Increase (decrease) in cash, cash equivalents and restricted cash 59,637 Cash, cash equivalents and restricted cash at beginning of the period 109,601 Cash, cash equivalents and restricted cash at end of the period 169,238

O U T L O O K

13 SOP Phase 3.2 ramp up in Huzhou, followed by serial production. Expect R&D progress on additional new product launches. Anticipate 2026 localization of pack operations in Clarksville, TN. Develop New high margin market opportunities while prioritizing commercialization and sales of our next generation products. Expand market segments, operational efficiency, and manufacturing capacity. Maintain margin profile to achieve improved liquidity and profitability. 2026 Outlook Our Strategic Focus Accelerate the Path to Profitability Prioritize a disciplined transition to a cashflow-positive state by optimizing our R&D-to-production cycles and operational execution. Scale with Margin Integrity As we expand our global manufacturing footprint to meet market demand, our primary objective is to maintain our industry-leading gross margin profile through manufacturing excellence. Drive High-Value Market Capture Accelerate revenue growth by deploying our latest innovations into high-barrier segments where we have competitive advantages. The Path Forward: We intend to achieve these goals through relentless technical innovation, capturing new high-growth markets, and strategically expanding our global capacity.

A P P E N D I X

15 Non-GAAP Reconciliations ($ in thousands) Three-Months Ended Dec. 31 Twelve-Months Ended Dec. 31 2025 2024 2025 2024 Revenues 96,399 113,387 427,516 379,801 Cost of revenues (66,442) (71,867) (272,899) (260,249) Energy storage system impairment (28,998) - (32,507) - Gross profit (GAAP) 959 41,520 122,110 119,552 Gross margin 1.0% 36.6% 28.6% 31.5% Non-cash settled share-based compensation (included in cost of revenues) 32 89 216 3,479 Adjusted gross profit (non-GAAP) 991 41,609 122,326 123,031 Adjusted gross margin (non-GAAP) 1.0% 36.7% 28.6% 32.4% Three-Months Ended Dec. 31 Twelve-Months Ended Dec. 31 2025 2024 2025 2024 General and administrative expenses (23,708) (22,340) (57,821) (81,486) Research and development expenses (10,385) (8,774) (34,109) (41,065) Selling and marketing expenses (5,968) (6,996) (22,197) (22,576) Impairment loss of long-lived assets (2,742) (5,134) (4,142) (93,173) Operating expenses (GAAP) (42,803) (43,244) (118,269) (238,300) Non-cash settled share-based compensation (included in Operating expenses) 763 462 2,856 27,370 Adjusted operating expenses (non-GAAP) (42,040) (42,782) (115,413) (210,930)

16 Non-GAAP Reconciliations ($ in thousands) Three-Months Ended Dec. 31 Twelve-Months Ended Dec. 31 2025 2024 2025 2024 Net profit/loss (GAAP) 16,539 (82,323) (29,218) (195,457) Changes in fair value of warrant and convertible loan (51,881) 81,200 39,121 79,960 Non-cash settled share-based compensation 795 551 3,072 30,849 Adjusted net profit/loss (non-GAAP) (34,547) (572) 12,975 (84,648) Three-Months Ended Dec. 31 Twelve-Months Ended Dec. 31 2025 2024 2025 2024 Net profit/loss (GAAP) 16,539 (82,323) (29,218) (195,457) Interest expense, net 862 1,404 3,946 8,969 Benefit from income taxes (6,284) - (5,325) - Depreciation and amortization 8,384 7,809 33,131 30,832 EBITDA (non-GAAP) 19,501 (73,110) 2,534 (155,656) Changes in fair value of warrant liability and convertible loan (51,881) 81,200 39,121 79,960 Non-cash settled share-based compensation 795 551 3,072 30,849 Adjusted EBITDA (non-GAAP) (31,585) 8,641 44,727 (44,847)

FAQ

How did Microvast (MVST) perform financially in full-year 2025?

Microvast grew 2025 revenue 12.6% to $427.5 million and improved gross margin to 28.6%. GAAP net loss narrowed sharply to $29.2 million, while non-GAAP adjusted net profit reached $13.0 million and adjusted EBITDA turned positive at $44.7 million.

What were Microvast (MVST) results for the fourth quarter of 2025?

In Q4 2025, Microvast reported revenue of $96.4 million, a 15.0% year-over-year decline, and gross margin of 1.0%. GAAP net profit was $16.5 million, but non-GAAP adjusted net loss was $34.5 million, reflecting significant impairment charges and weaker quarterly profitability.

How did impairment charges impact Microvast (MVST) margins in 2025?

Microvast recorded a $32.5 million inventory impairment on specialized energy storage system components in 2025. Management noted this reduced full-year gross margin by 7.6 percentage points and drove Q4 2025 gross margin down to 1.0% after $29.0 million of related charges.

What is Microvast’s (MVST) liquidity and cash flow position at year-end 2025?

As of December 31, 2025, Microvast held $169.2 million in cash, cash equivalents and restricted cash, up from $109.6 million a year earlier. The company generated $75.9 million of net cash from operating activities, offsetting investing and modest net financing outflows.

Which regions drove Microvast (MVST) revenue growth in 2025?

In 2025, EMEA revenue rose 13% to $211.9 million and U.S. revenue increased 173% to $39.3 million. APAC revenue was $176.3 million, a slight 1% decline, as regulatory shifts in South Korea offset delivery growth elsewhere in the region.

What are Microvast’s (MVST) key operational plans and outlook for 2026?

For 2026, Microvast expects continued revenue growth and aims to maintain a strong gross margin position. Priorities include achieving serial production at the Huzhou Phase 3.2 expansion, starting pack line operations in Clarksville, Tennessee, and targeting high-barrier segments across EMEA, North America and APAC.

Filing Exhibits & Attachments

6 documents

Press Releases

• EX-99.1 EX-99.1 303.9 KB
• EX-99.2 EX-99.2 22.4 KB

Other Documents

• EX-101 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2.1 KB
• EX-101 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT 15.5 KB
• EX-101 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT 27.1 KB
• EX-101 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT 16.2 KB